ADORA2A and Alzheimer disease: In AD, according to the adenosine receptor balance theory proposed by Yan et al. [71], the decrease in A1R expression happens simultaneously with the increase in A2AR expression, leading to disruption in inhibition and excitation processes and, eventually, to cognitive dysfunction.